Author

Susanne Phil

Institution: Ascendis Pharma (Denmark)

Observed institution: Ascendis Pharma (Denmark)

OpenAlex ID: A5093006409

OR23-05 Log-term Efficacy And Safety Of Transcon PTH In Adults With Hypoparathyroidism: 52-week Results From The Open-label Extension Of The Phase 3 Pathway Trial

2023 · Bart Clarke, Aliya Aziz Khan, et al. · Journal of the Endocrine Society · 2

Works count: 1

Citation count: 2

H-index: 1

I10-index: